Inactive Instrument
Quotes GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
||
| 13.64 EUR | 0.00% |
|
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Basic data
Market Cap (EUR)
688,333,308
Market Cap (USD)
784,783,158
Net sales (EUR)
71,115,000
Net sales (USD)
81,079,694
Free-Float
86.88 %
Free-Float capitalization (EUR)
598,205,955
Free-Float capitalization (USD)
682,027,083
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 785M | |
| +1.62% | +2.41% | +2.77% | +9.38% | 49.42B | |
| +0.74% | +0.74% | +394.92% | +600.64% | 40.34B | |
| +1.78% | -1.86% | +25.40% | -7.41% | 34.01B | |
| +0.98% | +1.91% | +18.63% | +57.55% | 33.56B | |
| -0.79% | +1.32% | +5.78% | +36.42% | 26.84B | |
| +0.91% | +1.32% | - | - | 17.22B | |
| +1.57% | -5.06% | +64.94% | +118.93% | 15.19B | |
| -18.90% | -16.19% | +60.06% | +64.09% | 13.96B | |
| +1.70% | -1.36% | +14.24% | +19.78% | 13.36B | |
| Average | -1.16% | +1.48% | +73.34% | +112.42% | 24.47B | |
| Weighted average by Cap. | -0.03% | +1.54% | +87.03% | +133.75% |
Historical Quotes: GENFIT
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Quotes GENFIT
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
